SULLA Drug Patent Profile
✉ Email this page to a colleague
When do Sulla patents expire, and when can generic versions of Sulla launch?
Sulla is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in SULLA is sulfameter. Additional details are available on the sulfameter profile page.
Summary for SULLA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 111 |
Patent Applications: | 1,768 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SULLA at DailyMed |
US Patents and Regulatory Information for SULLA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | SULLA | sulfameter | TABLET;ORAL | 016000-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |